malignancy
Showing 1 - 25 of 72
Cardiovascular Toxicity: Comprehensive Myocardial and Vascular
Recruiting
- Cardiovascular Diseases
- +7 more
- Cardiovascular magnetic resonance with stress perfusion
- +4 more
-
London, United KingdomSt Bartholomews Hospital
Sep 15, 2023
Hydronephrosis; Obstruction, Ureter, Renal Failure, Malignancy Trial in Petah Tikva, Ramat Gan (ureteral stent\s insertion)
Not yet recruiting
- Hydronephrosis; Obstruction, Ureter
- +4 more
- ureteral stent\s insertion
-
Petah Tikva, Israel
- +1 more
Aug 8, 2023
Cancer, Malignancy, Malignant Tumor Trial (Digital Intervention, Community Outreach)
Not yet recruiting
- Cancer
- +2 more
- Digital Intervention
- Community Outreach
- (no location specified)
May 23, 2023
Prostate Disease, Malignancy, Benign Prostatic Hyperplasia Trial in Boston (Self-Administered Nitrous Oxide, Oxygen)
Completed
- Prostate Disease
- +6 more
- Self-Administered Nitrous Oxide
- Oxygen
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Mar 25, 2023
Malignancy Trial in Beijing (Al18F-PSMA-BCH PET/CT)
Recruiting
- Malignancy
- Al18F-PSMA-BCH PET/CT
-
Beijing, Chaoyang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Mar 7, 2023
Abdominal Cancer, Malignancy Trial in Pittsburgh (Lipopolysaccharide)
Recruiting
- Abdominal Cancer
- Malignancy
- Lipopolysaccharide
-
Pittsburgh, Pennsylvania
- +1 more
Feb 28, 2023
Malignancy Trial in Beijing (Al18F-NOTA-FAPI)
Recruiting
- Malignancy
-
Beijing, Chao Yang, ChinaNational Cancer Center/Cancer Hospital,Chinese Academy of Medica
Feb 19, 2023
Malignancy, Metastasis, Hemoptysis Trial in Saint Louis (Volumetric MR imaging, Radiation therapy)
Completed
- Malignancy
- +6 more
- Volumetric MR imaging
- Radiation therapy
-
Saint Louis, MissouriWashington University School of Medicine
Jan 4, 2023
GVHD, Malignancy Trial in Canada, United States (Abatacept, )
Active, not recruiting
- Graft vs Host Disease
- Malignancy
- Abatacept
- placebo
-
Los Angeles, California
- +13 more
Jan 9, 2023
Cancer, Urinary Obstruction, Malignancy Trial in Chicago (Ureteral Stent, Percutaneous Nephrostomy Tube Placement)
Not yet recruiting
- Cancer
- +5 more
- Ureteral Stent
- Percutaneous Nephrostomy Tube Placement
-
Chicago, IllinoisThe University of Chicago
Nov 28, 2022
Cancer, End Stage Cancer, Malignancy Trial in Baltimore (Community Health Worker (CHW) based palliative care)
Enrolling by invitation
- Cancer
- +3 more
- Community Health Worker (CHW) based palliative care
-
Baltimore, MarylandJohns Hopkins University School of Medicine
Nov 8, 2022
Research Data and Samples From Patients Who Experience
Recruiting
- Malignancy
- Biospecimen Collection
- Medical Chart Review
-
Anchorage, Alaska
- +518 more
Sep 25, 2022
Lymphoproliferative Disorder, HHV-8, Malignancy Trial run by the National Cancer Institute (NCI) (Etoposide, Interferon-alpha,
Active, not recruiting
- Lymphoproliferative Disorder
- +3 more
- Etoposide
- +13 more
-
Bethesda, MarylandNational Institutes of Health Clinical Center, 9000 Rockville Pi
Aug 24, 2022
Information Needs Around Parenteral nUTrition in Cancer
Completed
- Cancer
- +6 more
- Non-interventional study
-
London, United Kingdom
- +3 more
Jul 14, 2022
Cardiovascular Disease and Cancer in Korean Population: A
Not yet recruiting
- Cardiovascular Diseases
- +2 more
-
Ulsan, Korea, Republic ofUlsan University Hospital
May 21, 2022
Covid19, Cancer, Malignancy Trial in Tucson (SARS-COV2 Pfizer Vaccine)
Completed
- Covid19
- +3 more
- SARS-COV2 Pfizer Vaccine
-
Tucson, ArizonaUniversity of Arizona
May 19, 2022
Cancer, Malignancy, Refractory Cancer Trial in Singapore (Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted ?d T
Not yet recruiting
- Cancer
- +3 more
- Allogeneic NKG2DL-targeting Chimeric Antigen Receptor-grafted γδ T Cells (CTM-N2D)
-
Singapore, SingaporeNational University Hospital
Mar 20, 2022
Solid Tumor, Carcinoma, Malignancy Trial in Hong Kong (propofol, sevoflurane)
Recruiting
- Solid Tumor
- +3 more
-
Hong Kong, Hong KongHong Kong Children's Hospital
Mar 14, 2022
Malignancy, Immune System Diseases, Autoimmune Diseases Trial in Chapel Hill (Biospecimen Collection, Medical Chart Review,
Recruiting
- Malignancy
- +2 more
- Biospecimen Collection
- +2 more
-
Chapel Hill, North CarolinaLineberger Comprehensive Cancer Center at University of North Ca
Feb 11, 2022
Advanced or Metastatic Solid Tumors, Malignancy, Metastasis Trial in Kurralta Park (AK114)
Not yet recruiting
- Advanced or Metastatic Solid Tumors
- +2 more
-
Kurralta Park, South Australia, AustraliaAshford Cancer Centre
Jan 7, 2022
Malignancy Trial in Shenzhen (Decitabine combined with NK cell infusion)
Recruiting
- Malignancy
- Decitabine combined with NK cell infusion
-
Shenzhen, Guangdong, ChinaShenzhen University General hospital
Nov 22, 2021